Philadelphia-positive chronic myelogenous leukemia with a 5q- abnormality in a patient following interferon-alpha therapy

Cancer Genetics and Cytogenetics

Volumn 127, Issue 2, 2001, Pages 134-139

  Zámečníkova, Adriana ^a   Križana, Peter ^a   Gyarfáš, Ján ^a   Vahančík, Alojz ^b  

^a CANCER RESEARCH INSTITUTE   (Slovakia)

^b Derer 's University Hospital Slovakia   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; DOXORUBICIN; HYDROXYUREA; MESSENGER RNA; PREDNISONE; RECOMBINANT ALPHA INTERFERON; VINCRISTINE;

ADULT; ARTICLE; BLOOD CELL; BONE MARROW CELL; CASE REPORT; CHROMOSOME 5Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION 5; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; DISEASE COURSE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REMISSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; ANTINEOPLASTIC AGENTS; BLAST CRISIS; BONE MARROW CELLS; CHROMOSOME BANDING; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 5; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERFERON-ALPHA; KARYOTYPING; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0034967660     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(00)00434-9     Document Type: Article

References (25)

1. Chronic myelogenous leukemia; a concise update
2. Chronic myelogenous leukemia; update of biology and treatment
3. Cytogenetic findings in chronic myeloid leukemia (CML); evaluation of karyotype, blast morphology, and survival in the acute phase
4. Interferon alpha-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia
5. Interferon alpha-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia
6. Variable numbers of BCR-ABL transcripts persist in CML patients who achieved complete cytogenetic remission with interferon-α
7. Suppression of cell proliferation and the expression of a bcr-abl fusion gene and apoptopic cell death in a new human myelogenous leukemia cell line KT-1, by interferon-A
8. Emergence of unusual cytogenetic abnormalities under interferon-alpha therapy in patients with chronic myelogenous leukemia
9. Aberrant cytogenetic evolution pattern of Philadelphia-positive chronic myeloid leukemia treated with interferon-alpha
10. Chromosomal aberrations during interferon therapy for chronic myelogenous leukemia
11. Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia; report of three cases
12. Acute blast transformation in CML patients still showing cytogenetic response to IFN-α n1 and the presence of cytogenetic abnormalities in Ph negative cells
13. Long arm deletion of chromosome no. 5 in a case of Philadelphia chromosome-positive chronic myelocytic leukemia
14. Ph-positive chronic myelogenous leukemia with a 5q- chromosome abnormality terminating in erythroblastic crisis
15. Association of the Philadelphia chromosome and 5q- in secondary blood disorder
16. 5q- in a case of blastic phase chronic myeloid leukemia
17. 5q-, twenty-five years later; a synopsis
18. Interferon regulatory factor 1 induces the expression of the interferon-stimulated genes
19. Introduction of interferon regulatory factors, 2 -5 oligoadenylate synthetase, P68 kinase and RNAase L in chronic myelogenous leukemia cells and its relationship to clinical responsives (1996)
20. Interferon regulatory factors-the next generation
21. Regulation of the interferon system, immune response and oncogenesis by the transcription factor interferon regulatory factor-1
22. Expression of interferon regulatory factor (IRF) gene and response to interferon-A in chronic myelogenous leukemia